Brexpiprazole CAS 913611-97-9 Mimọ> 99.0% (HPLC) API Aworan Ifihan

Brexpiprazole CAS 913611-97-9 Mimọ>99.0% (HPLC) Ile-iṣẹ API

Apejuwe kukuru:

Orukọ kemikali: Brexpiprazole

CAS: 913611-97-9

Mimọ:> 99.0% (HPLC)

Irisi: Funfun tabi Paa-White Crystalline Powder

API Didara Giga, Iṣelọpọ Iṣowo

E-Mail: alvin@ruifuchem.com

Fi imeeli ranṣẹ si wa

Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Ruifu Kemikali Ipese Brexpiprazole Intermediates
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo [b] thiophene CAS 5118-13-8
1- (1-Benzothiophen-4-yl) piperazine Hydrochloride CAS 913614-18-3
7- (4-Chlorobutoxy) quinolin-2 (1H) -ọkan CAS 913613-82-8
4-Chlorobenzo [b] thiophene CAS 66490-33-3

Kemikali Properties:

Orukọ Kemikali	Brexpiprazole
Awọn itumọ ọrọ sisọ	OPC-34712;7- (4- (4- (Benzo [b] thiophen-4-yl) piperazin-1-yl)butoxy) quinolin-2 (1H) -ọkan
Nọmba CAS	913611-97-9
NỌMBA CAT	RF-PI1982
Iṣura Ipo	Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu
Fọọmu Molecular	C25H27N3O2S
Òṣuwọn Molikula	433.57
iwuwo	1,245 ± 0,060 g / cm3
Brand	Ruifu Kemikali

Awọn pato:

Nkan	Awọn pato
Ifarahan	Funfun tabi Pa-White Crystalline Powder
Idanimọ	Nipasẹ IR
RT	Labẹ chirality yẹ ki o ni ibamu
Kloride	O funni ni esi ti kiloraidi
Omi	3.0% ~ 4.5%
Ojuami Iyo	198.0 ~ 202.0 ℃
Aloku lori Iginisonu	<0.20%
Awọn irin Heavy	≤10ppm
Awọn nkan ti o jọmọ
Olukuluku Aimọ	<0.50%
Lapapọ Awọn Aimọ	<1.00%
EE	> 99.0%
Mimọ / Analysis Ọna	> 99.0% (HPLC, lori ipilẹ gbigbẹ)
Igbeyewo Standard	Standard Enterprise
Lilo	API

Package & Ibi ipamọ:

Package: Igo, apo bankanje aluminiomu, 25kg / Paali ilu, tabi gẹgẹ bi ibeere alabara

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin

Awọn anfani:

FAQ:

Ohun elo:

Brexpiprazole (CAS: 913611-97-9) jẹ oludije oogun ti o wulo ni itọju ati idena awọn rudurudu ọpọlọ pẹlu awọn rudurudu CNS.Brexpiprazole jẹ oogun apakokoro aramada aramada eyiti o ṣe iranṣẹ bi serotonin ® oluyipada iṣẹ ṣiṣe dopamine ati pe o ti ṣe afihan imunadoko bi itọju ajumọṣe ni awọn alaisan ti o ni rudurudu irẹwẹsi nla (MDD).Brexpiprazole ṣe afihan profaili elegbogi alailẹgbẹ kan, ti n ṣiṣẹ bi agonist apa kan ti serotonin 5-HT1A ati awọn olugba dopamine D2 ati bi antagonist kikun ti 5-HT2A ati awọn olugba noradrenaline α1B/2C, pẹlu iru isunmọ isọdọkan subnanomolar.Brexpiprazole jẹ idagbasoke nipasẹ Otsuka ati Lundbeck, ti a fọwọsi ni ọdun 2015 nipasẹ FDA fun itọju schizophrenia ati bi itọju ajunsi fun ibanujẹ.Brexpiprazole ni a gba pe o jẹ arọpo si oogun antipsychotic Otsuka aripiprazole (orukọ iṣowo Abilify) eyiti itọsi rẹ pari ni Oṣu Kẹjọ ọdun 2014.